50 of the Top 250 law firms use our Products every day
Anadys
Pharmaceuticals, Inc.
Executive Officer Bonus
Plan
The bonus plan
is intended to:
|
|
a.
|
|
Strengthen the connection between
individual compensation and Company success, enhancing our ability
to achieve the Corporate Goals (as determined by our Board of
Directors) and enhance shareholder value
|
|
|
|
|
|
|
|
b.
|
|
Encourage teamwork among all
disciplines within the Company
|
|
|
|
|
|
|
|
c.
|
|
Reinforce the Company’s
pay-for-performance philosophy by awarding higher bonuses to higher
performing employees
|
|
|
|
|
|
|
|
d.
|
|
Help ensure that the Company’s
overall cash compensation for executive officers is
competitive
|
The
Compensation Committee of the Board of Directors (the
“Committee”) is responsible for reviewing and approving
the Plan and any proposed modifications to the Plan. The Committee
is also responsible for determining final bonus award amounts under
the Plan for all Executive Officers. Notwithstanding any provisions
of the Plan, the Compensation Committee retains absolute discretion
to determine whether any bonus payments will be made in a
particular year and the amount of any bonus payments. Bonus
determinations under this Plan will be made on an annual basis for
the applicable calendar year (each a “Plan
Year”).
In order to be
eligible to receive any bonus award under this Plan, a participant
(a) must have commenced his/her employment with the Company
prior to October 1 st of
the Plan Year and remained continuously employed through the end of
the Plan Year; (b) must be an employee in good standing (i.e.,
not on a performance improvement plan or an Unacceptable
Performance performer (performance category = 1)), and
(c) must be an executive officer of the Company as of October
1 st
of the Plan Year.
Bonus awards
will be paid annually in cash, based on achievement of the Plan
Year Corporate Goals and individual performance. Bonus awards will
be calculated by using the base salary, bonus opportunity,
weighting factor, and performance-based multipliers as set forth
below (pro-ration will be applied for those employees employed less
than the full year and for salary changes during the year). Bonus
awards will generally be paid on or about January 15 of the
year immediately following the Plan Year, though this timing may be
altered at the discretion of the Committee.
Bonus
Opportunity; Weighting Factors:
The bonus
opportunity and weighting factors will be reviewed annually and
adjusted as necessary or appropriate. The bonus opportunities and
weightings for the initial Plan Year and for subsequent years
unless and until adjusted will be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100% Bonus
|
|
Corporate
|
|
Individual
|
|
|
|
Opportunity
|
|
Performance
|
|
Performance
|
|
|
|
(as percentage of
|
|
Weighting
|
|
Weighting
|
|
Position
|
|
base salary)
|
|
Factor
|
|
Factor
|
|
|
|
|
50
|
%
|
|
|
90
|
%
|
|
|
10
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sr. VP, Drug Development & CMO and Sr. VP,
Legal Affairs & General Counsel
|
|
|
40
|
%
|
|
|
85
|
%
|
|
|
15
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
|
%
|
|
|
80
|
%
|
|
|
20
|
%
|
|